ArticlePharmaceuticals (Basel, Switzerland)2022
Identification of Novel Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors by Exploring the Primer Grip Region.
Tao Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.